These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2476118)

  • 1. Characterization of antilipolytic action of polyamines in isolated rat adipocytes.
    Richelsen B; Pedersen SB; Hougaard DM
    Biochem J; 1989 Jul; 261(2):661-5. PubMed ID: 2476118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of different phosphodiesterase inhibitors on the antilipolytic action of insulin in human adipocytes.
    Kather H; Scheurer A
    Horm Metab Res; 1987 Aug; 19(8):379-81. PubMed ID: 2822563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism.
    Shechter Y
    Endocrinology; 1984 Nov; 115(5):1787-91. PubMed ID: 6208014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antilipolytic effect of insulin does not require adenylate cyclase or phosphodiesterase action.
    Gabbay RA; Lardy HA
    FEBS Lett; 1985 Jan; 179(1):7-11. PubMed ID: 2981181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes.
    Xue B; Greenberg AG; Kraemer FB; Zemel MB
    FASEB J; 2001 Nov; 15(13):2527-9. PubMed ID: 11641262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylxanthine and non-xanthine phosphodiesterase inhibitors. Their effects on adenosine uptake and the low Km cyclic AMP phosphodiesterase in intact rat adipocyte.
    Wong EH; Ooi SO
    Biochem Pharmacol; 1985 Aug; 34(16):2891-6. PubMed ID: 2411270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes.
    Kuppusamy UR; Das NP
    Biochem Pharmacol; 1992 Oct; 44(7):1307-15. PubMed ID: 1384499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antilipolytic effect of insulin in human adipocytes requires activation of the phosphodiesterase.
    Lönnroth P; Smith U
    Biochem Biophys Res Commun; 1986 Dec; 141(3):1157-61. PubMed ID: 2434081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization of adenosine receptor-mediated inhibition of lipolysis. The mechanism involves the development of enhanced cyclic adenosine monophosphate accumulation in tolerant adipocytes.
    Hoffman BB; Chang H; Dall'Aglio E; Reaven GM
    J Clin Invest; 1986 Jul; 78(1):185-90. PubMed ID: 3013937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells.
    de Mazancourt P; Lacasa D; Giot J; Giudicelli Y
    Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of verapamil on lipolysis due to dibutyryl cyclic AMP.
    Goko H; Takashima S; Shimizu S; Kagawa S; Matsuoka A
    Biochem J; 1984 May; 220(1):321-4. PubMed ID: 6204645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of alkylxanthines and other phosphodiesterase inhibitors on adenosine-receptor mediated decrease in lipolysis and cyclic AMP accumulation in rat fat cells.
    Fredholm BB; Lindgren E
    Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):64-71. PubMed ID: 6322517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antilipolytic action of insulin on adrenocorticotrophin-stimulated rat adipocytes. The roles of adenosine 3',5'-monophosphate and the protein kinase dependent on adenosine 3',5'-monophosphate.
    Wong EH; Loten EG
    Eur J Biochem; 1981 Mar; 115(1):17-22. PubMed ID: 6262080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergic effect of insulin and prostaglandin E1 on stimulated lipolysis.
    Lambert B; Jacquemin C
    Prostaglandins Med; 1980 Nov; 5(5):375-82. PubMed ID: 6161382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3T3-L1 adipocytes.
    Zhou L; Wang X; Yang Y; Wu L; Li F; Zhang R; Yuan G; Wang N; Chen M; Ning G
    Biochim Biophys Acta; 2011 Apr; 1812(4):527-35. PubMed ID: 20969954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antilipolytic effect of prostaglandin E2 in perifused rat adipocytes.
    Richelsen B; Pedersen SB
    Endocrinology; 1987 Oct; 121(4):1221-6. PubMed ID: 3308432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cyclic AMP accumulation in hamster adipocytes with phosphatidic acid: differences and similarities with alpha adrenergic effects.
    Schimmel RJ; Honeyman TW; McMahon KK; Serio R; Clark RB
    J Cyclic Nucleotide Res; 1980; 6(6):437-49. PubMed ID: 6163805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, reverses the inhibitory effect of insulin on lipolysis due to dibutyryl cyclic AMP.
    Goko H; Matsuoka A
    Diabetes Res Clin Pract; 1993 Mar; 19(3):177-81. PubMed ID: 7686456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cAMP-dependent protein kinase and lipolysis in rat adipocytes. II. Definition of steady-state relationship with lipolytic and antilipolytic modulators.
    Honnor RC; Dhillon GS; Londos C
    J Biol Chem; 1985 Dec; 260(28):15130-8. PubMed ID: 3877723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.